Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Virginie Lemiale, Sandrine Valade & Eric Mariotte. (2021) Unresponsive Thrombotic Thrombocytopenic Purpura (TTP): Challenges and Solutions. Therapeutics and Clinical Risk Management 17, pages 577-587.
Read now
Read now
Articles from other publishers (14)
ACY Tso, CLL Sum & KH Ong. (2022) Reference range for ADAMTS13 antigen, activity and anti-ADAMTS13 antibody in the healthy adult Singapore population. Singapore Medical Journal 63:4, pages 214-218.
Crossref
Crossref
Tran Nguyen, Saikripa M Radhakrishnan, Srinidhi J Radhakrishnan & David H Johnson. (2022) Near-complete vision recovery from bilateral serous retinal detachment associated with thrombotic thrombocytopenic purpura. BMJ Case Reports 15:2, pages e244030.
Crossref
Crossref
Alexey Maschan, Uliana Petrova, Irina Kalinina, Elena Kurnikova, Daria Fedorova, Dina Baidildina, Natalia Kotskaya, Pavel Avdonin & Galina Novichkova. (2020) Bortezomib induces long‐term remission in children with immune thrombotic thrombocytopenic purpura, refractory to plasma exchange, glucocorticoids, and rituximab: A report on two cases. Pediatric Blood & Cancer 68:4.
Crossref
Crossref
Ruo‐Yun Gui, Qiu‐Sha Huang, Xuan Cai, Jin Wu, Hui‐Xin Liu, Yi Liu, Lin‐Hua Yang, Jing‐Yu Zhang, Yun‐Feng Cheng, Ming Jiang, Min Mao, Mei‐Yun Fang, Hui Liu, Li‐Ru Wang, Zhao Wang, He‐Bing Zhou, Hai Lan, Zhong‐Xing Jiang, Xu‐Liang Shen, Lei Zhang, Sheng‐Jin Fan, Yueying Li, Qian‐Fei Wang, Xiao‐Jun Huang & Xiao‐Hui Zhang. (2020) Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data. British Journal of Haematology 191:2, pages 269-281.
Crossref
Crossref
Christoph Königs. 2020. The Autoimmune Diseases. The Autoimmune Diseases
935
958
.
Veronika Kaczmarek, Johannes Holle, Rebekka Astudillo, Caroline Kempf, Philip Bufler & Dominik Müller. (2019) Caplacizumab for relapsing thrombotic thrombocytopenic purpura. Pediatric Nephrology 34:9, pages 1625-1628.
Crossref
Crossref
Fangfang Sun, Xiaodong Wang, Wanlong Wu, Kaiwen Wang, Zhiwei Chen, Ting Li & Shuang Ye. (2017) TMA secondary to SLE: rituximab improves overall but not renal survival. Clinical Rheumatology 37:1, pages 213-218.
Crossref
Crossref
Tamam Bakchoul & Andreas Greinacher. 2016. Molecular and Cellular Biology of Platelet Formation. Molecular and Cellular Biology of Platelet Formation
327
349
.
E Becerra, M A Scully, M J Leandro, E O Heelas, J-P Westwood, I De La Torre & G Cambridge. (2015) Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura. Clinical and Experimental Immunology 179:3, pages 414-425.
Crossref
Crossref
Klára Gadó & Gyula Domján. (2014) Thrombocytopenia. Orvosi Hetilap 155:8, pages 291-303.
Crossref
Crossref
Jae Il Shin & Michael Eisenhut. (2014) A beneficial effect of rituximab on autoimmune thrombotic thrombocytopenic purpura: Just a B-cell depletion?. Journal of Allergy and Clinical Immunology 133:2, pages 600.
Crossref
Crossref
Christoph Königs. 2014. The Autoimmune Diseases. The Autoimmune Diseases
711
731
.
Ralitza Martin, Annette Esper & Greg S. Martin. 2014. Non-Pulmonary Complications of Critical Care. Non-Pulmonary Complications of Critical Care
61
103
.
Neil Shah & Ravi Sarode. (2013) Thrombotic thrombocytopenic purpura-what is new?. Journal of Clinical Apheresis 28:1, pages 30-35.
Crossref
Crossref